vTv Therapeutics (VTVT) Net Margin: 2014-2025
Historic Net Margin for vTv Therapeutics (VTVT) over the last 10 years, with Sep 2025 value amounting to 173,960.00%.
- vTv Therapeutics' Net Margin was N/A to 173,960.00% in Q3 2025 from the same period last year, while for Sep 2025 it was -2,335.32%, marking a year-over-year change of. This contributed to the annual value of -1,815.34% for FY2024, which is 2146052.00% up from last year.
- vTv Therapeutics' Net Margin amounted to 173,960.00% in Q3 2025, which was up 913.79% from -21,376.47% recorded in Q4 2024.
- Over the past 5 years, vTv Therapeutics' Net Margin peaked at 280,950.00% during Q2 2023, and registered a low of -78,344.44% during Q4 2021.
- In the last 3 years, vTv Therapeutics' Net Margin had a median value of 49,685.71% in 2023 and averaged 92,083.39%.
- Its Net Margin has fluctuated over the past 5 years, first crashed by 7,836,956bps in 2021, then soared by 31,596,111bps in 2023.
- vTv Therapeutics' Net Margin (Quarterly) stood at -78,344.44% in 2021, then surged by 2,562,222bps to -52,722.22% in 2022, then skyrocketed by 10,240,794bps to 49,685.71% in 2023, then tumbled by 7,106,218bps to -21,376.47% in 2024, then reached 173,960.00% in 2025.
- Its last three reported values are 173,960.00% in Q3 2025, -21,376.47% for Q4 2024, and -486.50% during Q1 2024.